Creating businesses in new fields such as biomedicine
First written in FY2016. 8 of 18 entries say "Restated". Latest entry: FY2027-H1.
0 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「The Company is also advancing the development of technologies and products in new mechatronics application areas, including physical AI, healthcare and pharmaceuticals, and food and agriculture, where it expects future market expansion.」
The Company continues to develop technologies and products in new fields, including biomedical and healthcare-related applications, while expanding into areas such as healthcare and pharmaceuticals. - FY2026AdvancedAnnual report
「Through a joint venture with Astellas Pharma Inc., we established セラファ・バイオサイエンス株式会社 to develop and provide a manufacturing platform for regenerative medicine and other products.」
The Biomedical Science field progressed from a joint development agreement to the establishment of a joint venture and the provision of a manufacturing platform for regenerative medicine and other products. - FY2025AdvancedAnnual report
「We entered into an agreement with Astellas Pharma Inc. to establish a joint venture that will develop and provide a manufacturing platform for cell therapy products using the general-purpose humanoid robot Maholo to startups and academia.」
The Biomedical Science field progressed from automation in genome analysis and regenerative medicine to an agreement with Astellas Pharma Inc. to establish a joint venture for a cell therapy product manufacturing platform. - FY2023AdvancedAnnual report
「Biomedical Science Through automation in genome analysis and regenerative medicine, we will create a future in which everyone can live richer, more fulfilling lives and shine as themselves.」
The target scope of the Humatronics and biomedical fields has expanded from genome analysis to automation in regenerative medicine. - FY2022AdvancedAnnual report
「In addition, in the Humatronics equipment business, we will strengthen the business foundation for biomedical robots in genome analysis and iPS cell culture.」
The target areas for commercialization in Humatronics have been specified to include genome analysis and iPS cell culture, in addition to rehabilitation and PCR testing. - FY2021AdvancedAnnual report
「In the Humatronics equipment business, we will strengthen efforts to deploy biomedical robots in PCR testing processes and commercialize the business in the field of genome analysis.」
In the Humatronics and biomedical fields, the company specified expansion beyond its previous focus on rehabilitation equipment development into applications in PCR testing processes and commercialization in genome analysis. - FY2020AdvancedAnnual report
「To expand the application of mechatronics, we commercialized the CoCoroe PR2 forearm pronation and supination rehabilitation device. The device is designed specifically for rehabilitation involving pronation and supination movements of the forearm and has obtained medical device certification in Japan as a controlled medical device (Class II) and a specially controlled medical device requiring maintenance.」
In the Humatronics and biomedical fields, the company progressed through commercialization of a rehabilitation device and acquisition of medical device certification. - FY2020-Q3RestatedAnnual report
「Humatronics: Building a business model by expanding demonstration projects for Humatronics equipment」
The company reaffirmed its policy of building a business model through expanded demonstration projects for Humatronics equipment. - FY2020-Q2ReframedAnnual report
「Humatronics: Building a business model by expanding demonstration projects for Humatronics equipment」
Humatronics has been positioned as being at the stage of building a business model by expanding equipment demonstration projects in addition to developing medical and welfare equipment. - FY2019AdvancedAnnual report
「To establish the Humatronics business area set out in the long-term management plan, the 2025 Vision, we developed a clinical research prototype of a forearm pronation and supination rehabilitation device.」
In the Humatronics and biomedical fields, the company progressed to the development stage for a clinical research prototype of a forearm rehabilitation device. - FY2019-Q2RestatedAnnual report
「In Humatronics, we are applying mechatronics technologies to the medical and welfare fields and developing products, including rehabilitation equipment and biomedical robots, that can contribute to society over the long term.」
The company continues its policy of applying mechatronics to the medical and welfare fields and developing rehabilitation equipment and biomedical robots. - FY2019-Q1RestatedAnnual report
「In Humatronics, we are applying mechatronics technologies to the medical and welfare fields and developing products, including rehabilitation equipment and biomedical robots, that can contribute to society over the long term.」
The company continues its policy of applying mechatronics to the medical and welfare fields and developing rehabilitation equipment and biomedical robots. - FY2018-Q2RestatedAnnual report
「In the Humatronics business, we are applying mechatronics technologies to the medical and welfare fields and developing products, including rehabilitation equipment and biomedical robots, that can contribute to society over the long term.」
As part of the Humatronics business, the company continues developing products for the medical and welfare fields and biomedical applications. - FY2017AdvancedAnnual report
「We have commercialized products including six-axis vertical articulated robots suitable for fields such as biomedical applications, where stringent hygiene controls are required.」
The company commercialized a six-axis vertical articulated robot for biomedical applications, reporting concrete product deployment in a new field. - FY2017-Q4RestatedAnnual report
「While expanding its product lineup, including servo drives, inverters and robots, the company is also advancing technology and product development in the medical and welfare fields and the environmental and energy business areas.」
The company continues technology and product development in new fields, including medical and welfare and environmental and energy applications. - FY2017-Q3RestatedAnnual report
「While expanding its product lineup, including servo drives, inverters and robots, the company is also advancing technology and product development in the Clean Power business area and the medical and welfare fields.」
The company continues technology and product development in new fields, including the medical and welfare fields. - FY2017-Q2RestatedAnnual report
「While expanding its product lineup, including servo drives, inverters and robots, the company is also advancing technology and product development in the medical and welfare fields and the environmental and energy business areas.」
The company continues technology and product development in new fields, including medical and welfare and environmental and energy applications. - FY2016First statedAnnual report
「We will pursue the creation of businesses in new fields, including biomedical applications.」
Biomedical applications were cited as an example, and the company set out its goal of creating businesses in new fields.